BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30185437)

  • 1. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
    Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
    Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
    De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
    Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
    Padi SKR; Luevano LA; An N; Pandey R; Singh N; Song JH; Aster JC; Yu XZ; Mehrotra S; Kraft AS
    Oncotarget; 2017 May; 8(18):30199-30216. PubMed ID: 28415816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
    Silva A; Gírio A; Cebola I; Santos CI; Antunes F; Barata JT
    Leukemia; 2011 Jun; 25(6):960-7. PubMed ID: 21455214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
    Melão A; Spit M; Cardoso BA; Barata JT
    Haematologica; 2016 Nov; 101(11):1368-1379. PubMed ID: 27470599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
    Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
    Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
    Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK1/2 induces STAT5-mediated germline transcription of the TCRgamma locus in response to IL-7R signaling.
    Maki K; Ikuta K
    J Immunol; 2008 Jul; 181(1):494-502. PubMed ID: 18566415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
    Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
    Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5 in B cell development and leukemia.
    Malin S; McManus S; Busslinger M
    Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
    Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
    Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
    Vranjkovic A; Crawley AM; Patey A; Angel JB
    J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
    Meyer LK; Huang BJ; Delgado-Martin C; Roy RP; Hechmer A; Wandler AM; Vincent TL; Fortina P; Olshen AB; Wood BL; Horton TM; Shannon KM; Teachey DT; Hermiston ML
    J Clin Invest; 2020 Feb; 130(2):863-876. PubMed ID: 31687977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.
    Zeng H; Yu M; Tan H; Li Y; Su W; Shi H; Dhungana Y; Guy C; Neale G; Cloer C; Peng J; Wang D; Chi H
    Sci Adv; 2018 Jan; 4(1):eaar5701. PubMed ID: 29399633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
    Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
    Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement.
    La Starza R; Messina M; Gianfelici V; Pierini V; Matteucci C; Pierini T; Limongi MZ; Vitale A; Roti G; Chiaretti S; Foà R; Mecucci C
    Leukemia; 2018 Aug; 32(8):1807-1810. PubMed ID: 29479063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.